XML 34 R20.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of income tax reconciliation
               
    Years Ended December 31,
    2022   2021
Tax benefit at U.S. statutory rate   $ (545,212 )   $ (409,203 )
State income taxes, net of federal benefit     (153,085 )     (25,607 )
Tax effect of foreign operations     2,285       47,428  
Non-deductible items     (31,914 )     5  
Valuation allowance     740,508       420,570  
Other     55,265       (18,138 )
 Income Tax Expense (Benefit)   $ 67,847     $ 15,055  
Schedule of income tax benefit
                 
    2022   2021
Current:                
 Federal   $ 55,278     $  
 State     800       823  
                 
Deferred:                
 Federal     (2,835 )     18,070  
 State     14,604       (3,838 )
Income Tax Expense (Benefit)   $ 67,847     $ 15,055  
Schedule of deferred tax assets and liabilities
               
    Years Ended December 31,
Deferred tax assets:   2022   2021
Accruals and allowances   $ 187,320     $ 82,906  
Stock based compensation     70,559       63,999  
Net operating allowances     1,338,208       705,996  
    1,596,087       852,901  
Deferred tax liabilities:                
Intangible assets     (285,379 )     (270,932 )
Valuation allowance     (1,596,087 )     (855,579 )
Net deferred tax assets and liabilities   $ (285,379 )   $ (273,610 )

 

Deferred tax assets are to be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. Management has considered the Company’s history of cumulative net losses incurred and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the deferred tax assets as of December 31, 2022 and 2021. Since indefinite-lived assets cannot be used as a source of taxable income to support the realization of deferred tax asset, a valuation allowance was recorded against the deferred tax assets, and a net deferred tax liability or naked credit of approximately $285,000 and $274,000 is presented on the company’s balance sheet, respectively. The Company’s valuation allowance increased by $319,938 in 2022.

 

The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While the Company believes that it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcome of examinations by tax authorities in determining the adequacy of its provision for income taxes.